全文获取类型
收费全文 | 6646篇 |
免费 | 1040篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 132篇 |
儿科学 | 197篇 |
妇产科学 | 128篇 |
基础医学 | 676篇 |
口腔科学 | 87篇 |
临床医学 | 1329篇 |
内科学 | 1747篇 |
皮肤病学 | 253篇 |
神经病学 | 483篇 |
特种医学 | 226篇 |
外国民族医学 | 18篇 |
外科学 | 1083篇 |
综合类 | 46篇 |
一般理论 | 1篇 |
预防医学 | 356篇 |
眼科学 | 162篇 |
药学 | 285篇 |
中国医学 | 6篇 |
肿瘤学 | 506篇 |
出版年
2024年 | 17篇 |
2023年 | 159篇 |
2022年 | 75篇 |
2021年 | 217篇 |
2020年 | 246篇 |
2019年 | 173篇 |
2018年 | 330篇 |
2017年 | 242篇 |
2016年 | 273篇 |
2015年 | 259篇 |
2014年 | 397篇 |
2013年 | 490篇 |
2012年 | 302篇 |
2011年 | 307篇 |
2010年 | 325篇 |
2009年 | 403篇 |
2008年 | 315篇 |
2007年 | 297篇 |
2006年 | 316篇 |
2005年 | 274篇 |
2004年 | 224篇 |
2003年 | 204篇 |
2002年 | 198篇 |
2001年 | 204篇 |
2000年 | 188篇 |
1999年 | 168篇 |
1998年 | 86篇 |
1997年 | 86篇 |
1996年 | 80篇 |
1995年 | 65篇 |
1994年 | 43篇 |
1993年 | 45篇 |
1992年 | 61篇 |
1991年 | 69篇 |
1990年 | 59篇 |
1989年 | 58篇 |
1988年 | 60篇 |
1987年 | 26篇 |
1986年 | 57篇 |
1985年 | 43篇 |
1984年 | 29篇 |
1983年 | 22篇 |
1982年 | 13篇 |
1979年 | 25篇 |
1978年 | 15篇 |
1976年 | 12篇 |
1974年 | 15篇 |
1972年 | 15篇 |
1971年 | 13篇 |
1970年 | 12篇 |
排序方式: 共有7721条查询结果,搜索用时 15 毫秒
1.
Jamaal L. Benjamin MD PhD Rebecca Dennis DO Stacy White Jr MD David Munson MD Sudha A. Anupindi MD Maciej Piskunowicz MD Kassa Darge MD PhD Ami Gokli MD Misun Hwang MD 《Journal of ultrasound in medicine》2020,39(5):1031-1036
Bowel diseases of prematurity, including necrotizing enterocolitis, are dreaded ailments of neonates. Early diagnosis is difficult, with clinical and radiographic findings often inconclusive. We present a novel use of contrast-enhanced ultrasound in detection of pediatric bowel disease. Early identification of compromised blood flow or an at-risk bowel can be quantitatively detected and monitored. This ability has implications for guidance of emerging therapies, allowing targeting of inflammation. These findings represent an advancement in detection of bowel disease in neonates. 相似文献
2.
3.
4.
5.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
6.
7.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献8.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
9.
Fibromyalgia is a syndrome of widespread pain, nonrestorative sleep, disturbed mood, and fatigue. Optimal treatment involves
a multidisciplinary approach with a team of health care providers using pharmacologic and nonpharmacologic treatment. Because
of the heterogeneity of the illness, management should be individualized for the patient. Pharmacologic treatment should address
issues of pain control, sleep disturbance, fatigue, and any underlying coexisting mood disorder. Nonpharmacologic treatment
should include patient education, a regular exercise and stretching program, and cognitive behavioral therapy. All of these
are essential to improving functional capacity and quality of life. This review provides general guidelines in initiating
a successful pharmacologic treatment program for patients with fibromyalgia. 相似文献
10.